Consult your oncologist before starting Letrozole. It’s crucial for personalized risk assessment and treatment planning.
Letrozole, an aromatase inhibitor, reduces estrogen production, significantly lowering breast cancer risk in postmenopausal women with high risk factors. This is particularly effective for women with a strong family history of breast cancer or those with atypical hyperplasia.
Typical treatment involves daily oral administration for a period determined by your doctor, often five years. Adherence to the prescribed dosage is paramount for optimal results.
Potential side effects include joint pain, hot flashes, and vaginal dryness. Your doctor will discuss management strategies for these, potentially including medication adjustments or supplemental therapies.
Regular check-ups, including bone density scans, are recommended to monitor potential side effects and overall health. Open communication with your healthcare provider is key throughout the treatment process.
Letrozole’s efficacy varies among individuals. Your doctor will consider your specific risk profile and health history to determine suitability.
Lifestyle choices play a crucial role alongside medication. Maintaining a healthy weight, regular exercise, and a balanced diet contribute to overall well-being and may further reduce breast cancer risk.
Remember, Letrozole is a preventative measure, not a guarantee against breast cancer. Consistent monitoring and proactive healthcare are essential.
